May 24, 2021 02:02 PM IST
With the launch of this new policy, the company intends to support the families of its employees amid the second wave of the coronavirus pandemic, Mankind Pharma said in a statement.
- Apr 26, 2021 05:01 PM IST
The company plans to start releasing the money with immediate effect and hopes to complete it within three months, Mankind Pharma said in a statement.
- Apr 21, 2021 03:37 PM IST
The Drug Controller General of India on April 12 approved the emergency use authorisation of Russia's Sputnik V COVID-19 vaccine.
- Aug 11, 2020 06:12 PM IST
Mankind Pharma and South Korean drug maker Daewoong Pharmaceutical will conduct human trials of niclosamide that has emerged as a promising candidate against COVID-19 because of its antiviral properties
- Dec 05, 2019 03:07 PM IST
With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement. The company's product is generic version of Abbott's Duphaston tablets, it added.
- Oct 30, 2017 02:21 PM IST
In a statement, Mankind Pharma CEO Rajeev Juneja said: "We believe this association will further add confidence to the brand and strengthen the Mankind brand image among consumers. We welcome Mr Bachchan to the Mankind family."
- May 16, 2017 04:12 PM IST
"At Mankind, we endeavour to bring the latest innovative therapies with assured quality that address primary healthcare challenge in India-world class quality at an affordable price," Mankind Group chairman and founder R C Juneja said in a statement.
- Mar 25, 2017 03:54 PM IST
Watch Mankind Pharma’s journey from being a small family-run enterprise to becoming present in over 15 countries around the world.
- Mar 17, 2016 07:00 PM IST
The 22 healthcare companies have sought quashing of the government's March 10 notification banning over 300 FDC drugs, including cough syrup compositions on the ground that they involve "risk" to humans and safer alternatives were available.
- Jan 21, 2016 02:15 PM IST
The investment in the US is being strategically done with an eye to place the company among top three Indian pharma firms in the US, Mankind Pharma today said in a statemen
- Nov 30, 2015 12:10 PM IST
Mankind Pharma recently launched anti-diabetic drug Gliptin under the brand name 'Dynaglipt' at Rs 8.5 per tablet for the patients and expects diabetes segment to contribute Rs 200 crore to the company's expected revenues of around Rs 4,200 crore for the fiscal.
- Nov 23, 2015 07:06 PM IST
The product, which has been approved by Drug Controller General of India, is priced at nearly Rs 600 for 30 days therapy to a patient
- Oct 15, 2015 05:00 PM IST
With a strategic approach on formulations, the company has been focusing on the manufacturing of nutraceuticals with a growth rate of 35 percent.
- Oct 13, 2015 03:44 PM IST
Part of the company's global investment of USD 1.2 billion, it is IBM's second such centre in India. The first one in Mumbai offers private cloud computing services.
- Jul 14, 2015 10:15 PM IST
Competition Commission has given its green signal to the proposed 11 percent stake sale in Mankind Pharma to two Mauritius-based private equity investors.
- Apr 06, 2015 06:40 PM IST
The Delhi-based firm, which manufactures various over-the-counter products including condoms, said the new facility would produce bulk APIs.
- Jan 13, 2012 06:23 PM IST
Chairman of Mankind Pharma, Ramesh Juneja, tells CNBC-TV18 that they aim to enter the league of top five in the pharma space in the next three years and reach the top slot by 2016.